Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
NCT06624865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2025-04-04
Summary
The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.
Conditions
- Small-intestine Neuroendocrine Tumors
Interventions
- OTHER
-
Blood and stool sampling
Blood and stool sampling
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-05
- Primary Completion
- 2029-10-31
- Completion
- 2029-10-31
Countries
- France
Study Locations
More Related Trials
-
Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
NCT06181201 ·Status: TERMINATED
-
Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study
NCT06924645 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Establishment of Individualized Immunotherapy Strategy and Platform Based on Changes of Intestinal Microbiota
NCT05065515 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy
NCT05273255 ·Status: COMPLETED ·Phase: NA
-
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
NCT04333004 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
NCT04264975 ·Status: RECRUITING ·Phase: NA
-
Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
NCT04721041 ·Status: RECRUITING ·Phase: NA
-
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach
NCT04567446 ·Status: RECRUITING
-
Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer
NCT06898359 ·Status: COMPLETED
-
Microbiome and Rectal Cancer
NCT04223102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364 ·Status: RECRUITING ·Phase: PHASE1
-
The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022
NCT07291752 ·Status: COMPLETED
-
Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer
NCT05079503 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT01651026 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
NCT06346093 ·Status: RECRUITING ·Phase: NA
-
Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer
NCT06714903 ·Status: RECRUITING
-
An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy
NCT07263620 ·Status: RECRUITING
-
Study of the Association Between Tumor Microenvironment Macrophages and Treatment Response in Squamous Cell Carcinoma of the Anal Canal
NCT05019235 ·Status: UNKNOWN
-
Immunotherapy Treating GI Cancer
NCT03614650 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
NCT01212510 ·Status: COMPLETED ·Phase: NA
-
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
NCT06849362 ·Status: ENROLLING_BY_INVITATION
-
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
NCT06403111 ·Status: RECRUITING ·Phase: PHASE2
-
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation
NCT04163289 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1